Reata Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REATA PHARMS, and what generic alternatives to REATA PHARMS drugs are available?
REATA PHARMS has one approved drug.
There are seven US patents protecting REATA PHARMS drugs.
There are ninety-seven patent family members on REATA PHARMS drugs in thirty-seven countries.
Drugs and US Patents for Reata Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reata Pharms | SKYCLARYS | omaveloxolone | CAPSULE;ORAL | 216718-001 | Feb 28, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Reata Pharms | SKYCLARYS | omaveloxolone | CAPSULE;ORAL | 216718-001 | Feb 28, 2023 | RX | Yes | Yes | 9,701,709 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
Reata Pharms | SKYCLARYS | omaveloxolone | CAPSULE;ORAL | 216718-001 | Feb 28, 2023 | RX | Yes | Yes | 8,124,799 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Reata Pharms | SKYCLARYS | omaveloxolone | CAPSULE;ORAL | 216718-001 | Feb 28, 2023 | RX | Yes | Yes | 11,091,430 | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Reata Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 102101774 | ⤷ Subscribe |
Canada | 2721838 | ⤷ Subscribe |
South Korea | 101735807 | ⤷ Subscribe |
Eurasian Patent Organization | 019263 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.